Literature DB >> 21454199

What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?

Sigurdur Y Kristinsson1, Ola Landgren.   

Abstract

Population-based studies suggest a role for chronic immune stimulation and genetic factors in the causation of lymphoplasmacytic lymphoma (LPL)/Waldenström's macroglobulinemia (WM). In this review we summarize and discuss our current understanding on etiology and pathogenesis of LPL/WM. We also highlight on gaps in the literature and propose future directions for population-based and molecular studies designed to expand our knowledge and uncover biological underpinnings of identified associations. Further, we address clinical implications and provide perspective on the relevance of these data for patient counseling and clinical follow-up.

Entities:  

Mesh:

Year:  2011        PMID: 21454199      PMCID: PMC7020666          DOI: 10.3816/CLML.2011.n.015

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


  22 in total

Review 1.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Authors:  Roger G Owen; Steven P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesus F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Journal:  Semin Oncol       Date:  2003-04       Impact factor: 4.929

2.  Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.

Authors:  Matthew F Rudd; Gabrielle S Sellick; Emily L Webb; Daniel Catovsky; Richard S Houlston
Journal:  Blood       Date:  2006-03-30       Impact factor: 22.113

3.  Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.

Authors:  Sigurdur Y Kristinsson; Jill Koshiol; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  J Natl Cancer Inst       Date:  2010-02-24       Impact factor: 13.506

4.  Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation.

Authors:  Regan H Royer; Jill Koshiol; Therese R Giambarresi; Linda G Vasquez; Ruth M Pfeiffer; Mary L McMaster
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

5.  Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland.

Authors:  T Hakulinen; H Isomaki; P Knekt
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965

6.  Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Ellen D Remstein; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

7.  Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2008-08-13       Impact factor: 22.113

8.  Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis.

Authors:  Stefan Hohaus; Giuseppina Massini; Francesco D'Alo'; Francesco Guidi; Rossana Putzulu; Alessandra Scardocci; Andras Rabi; Anna Laura Di Febo; Maria Teresa Voso; Giuseppe Leone
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

Review 9.  Genetic susceptibility to lymphoma.

Authors:  Christine F Skibola; John D Curry; Alexandra Nieters
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

10.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

View more
  2 in total

Review 1.  Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

Authors:  Seongseok Yun; Ariel C Johnson; Onyemaechi N Okolo; Stacy J Arnold; Ali McBride; Ling Zhang; Rachid C Baz; Faiz Anwer
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-03-07

Review 2.  Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.

Authors:  Prashant Kapoor; Jonas Paludo; Stephen M Ansell
Journal:  Curr Treat Options Oncol       Date:  2016-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.